Search results for "AGENT"

showing 10 items of 8904 documents

In vitro evaluation of the efficacy of two bleaching procedures

2010

Objective: In vitro comparison of the efficacy of two bleaching procedures, one based on carbamide peroxide (CP) and the other on hydrogen peroxide (HP), simulating clinical conditions. Study Design: Two groups of 20 teeth in each group were selected. Group A: 22% CP, one hour a day for 21 consecutive days. Group B: 37.5% HP, in 2 treatment sessions with an one week interval between each session. At each session the product was applied three successive times for eight minutes. Colour was recorded before treatment, when it was finished and one week after finishing it, with the Vita EasyShade spectrophotometer. CIEL*a*b* and ΔE were established at each moment in the study. Intra-group data wa…

medicine.medical_specialtybusiness.industryDentistryCarbamide PeroxideHydrogen PeroxideIn Vitro Techniques:CIENCIAS MÉDICAS [UNESCO]SurgeryPeroxideschemistry.chemical_compoundOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASTooth BleachingMedicineHumansUreaSurgeryCarbamide peroxidebusinessHydrogen peroxideTooth Bleaching AgentsGeneral Dentistry
researchProduct

Why do antidepressant therapies have such a poor success rate?

2016

Major depression is one of the leading global diseases [1,2]. Treatment is required, because untreated patients suffer not only from impaired emotion [3,4], but also from cognitive [4–6] and somati...

medicine.medical_specialtybusiness.industryDepressionGeneral NeuroscienceCognitionAntidepressive Agents030227 psychiatryPsychotherapy03 medical and health sciences0302 clinical medicineText miningMedicineAntidepressantHumansPharmacology (medical)Neurology (clinical)businessPsychiatry030217 neurology & neurosurgeryDepression (differential diagnoses)Expert review of neurotherapeutics
researchProduct

Daptomycin-induced eosinophilic pneumonia: Are there any risk factors?

2020

Abstract Objectives Daptomycin is a widely used antibiotic. Rhabdomyolysis related to daptomycin is one of the adverse effects of treatment, justifying the need for regular monitoring of muscle enzymes throughout treatment. Daptomycin may also lead to eosinophilic pneumonia. However, risk factors for this adverse reaction have not been identified and do not permit targeting of at-risk populations who could benefit from appropriate monitoring. Patients and methods Literature was reviewed for cases of daptomycin-induced eosinophilic pneumonia (DIEP), which that were compared to cases of patients without this adverse effect. Results Fifty patients with DIEP and 54 controls were identified. Age…

medicine.medical_specialtybusiness.industryDiseasemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesDaptomycinRisk FactorsInternal medicineDiabetes mellitusmedicineEosinophilic pneumoniaHumansDaptomycinRisk factorPulmonary EosinophiliaAdverse effectbusinessRhabdomyolysisPulmonary EosinophiliaLungmedicine.drugInfectious diseases now
researchProduct

Managing Resistant Hypertension: Not Just a Question of Numbers

2005

medicine.medical_specialtybusiness.industryDrug ResistanceResistant hypertensionBlood PressureBlood Pressure DeterminationDrug resistanceSurgeryDiagnosis DifferentialBlood pressureText miningRefractoryHypertensionPrevalenceInternal MedicinemedicineHumansDifferential diagnosisIntensive care medicinebusinessAntihypertensive AgentsAmerican Journal of Hypertension
researchProduct

Nonsteroid Immunosuppressants in Endocrine Orbitopathy

2009

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismAziridinesEndocrine orbitopathyGeneral MedicineDermatologyGraves DiseaseEndocrinologyAzathioprineCyclosporineInternal MedicinemedicineHumansbusinessCyclophosphamideImmunosuppressive AgentsExperimental and Clinical Endocrinology & Diabetes
researchProduct

Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.

2007

Proton pump inhibitors (PPIs) are antisecretory agents that are widely used in the short- and long-term management of gastroesophageal reflux disease (GERD) to relieve symptoms, heal esophagitis, and prevent complications, such as strictures and Barrett’s esophagus. The total healthcare costs of GERD are high, especially for maintenance treatment. Therefore, the choice of cost-effective therapeutic options is an ineluctable challenge for public health authorities, third-party payers, and patients. In some European Union countries, a recent trend of public health authorities is to promote the choice of less expensive PPIs, regardless of their antisecretory potency – this in spite of the evid…

medicine.medical_specialtybusiness.industryGastroenterologyRefluxAntisecretory agentsEsomeprazoleProton Pump InhibitorsDiseaseProton pump inhibitorGastroesophageal reflux diseasemedicine.diseaseGastroenterologydigestive system diseasesInternal medicineGERDmedicineGastroesophageal RefluxHumansbusinessEsophagitisTherapy optimizationRandomized Controlled Trials as TopicDigestion
researchProduct

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk

2005

Abstract Background. Management of patients with suspected Pulmonary Embolism (PE) is problematic if diagnostic imaging is not available. Pretest Clinical Probability (PCP) and D-dimer (D-d) assessment were shown to be useful to identify those high risk patients for whom empirical, protective anticoagulation is indicated (Siragusa S et al. Arch Intern Med2004;164:2477–82). Objective of the study. In consecutive patients with suspected PE, we evaluated whether PCP and D-d assessment, together with the use of low molecular weight heparins (LMWHs), allow objective appraisal of PE to be deferred for up to 72 hours. Methods. In case of deferment of diagnostic imaging for PE, patients identified …

medicine.medical_specialtybusiness.industryImmunologyCell BiologyHematologymedicine.diseaseBiochemistryVentilation/perfusion ratioConfidence intervalSurgeryPulmonary embolismObjective assessmentInternal medicineAntithromboticMedicinebusinessPerfusionVenous thromboembolismFibrinolytic agent
researchProduct

Pulmonary thromboembolism associated with the use of new antipsychotics in a paediatric patient.

2020

medicine.medical_specialtybusiness.industryMEDLINEText miningThromboembolismPediatrics Perinatology and Child HealthmedicineHumansIntensive care medicinebusinessChildPulmonary EmbolismPaediatric patientsAntipsychotic AgentsJournal of paediatrics and child healthReferences
researchProduct

Octreotide prevents the pathological alterations of bowel obstruction in cancer patients

1996

medicine.medical_specialtybusiness.industryNursing researchPain medicineGeneral surgeryOctreotideCancerOctreotidemedicine.diseaseGastroenterologyIntestinesBowel obstructionGastrointestinal AgentsOncologyNeoplasmsInternal medicinePreoperative CaremedicineHumansbusinessPathologicalIntestinal Obstructionmedicine.drugSupportive Care in Cancer
researchProduct

Role of the hospital pharmacist in an Italian antimicrobial stewardship programme

2020

The inappropriate use of antimicrobial agents is contributing to an increasing phenomenon of bacterial resistance. For this reason, there is a growing interest in ‘antimicrobial stewardship’, a series of coordinated and multidisciplinary interventions aimed to promote the safe and appropriate use of antimicrobials in which the pharmacist’s contribution is necessary for the optimal choice of drug, dose, duration of therapy and the implementation of cost containment strategies. AIM OF THE STUDY: We wanted to create a reference model and a specific training manual on antibiotic stewardship to introduce the role of the department pharmacist with specific infection disease skills in the Italian …

medicine.medical_specialtybusiness.industryPsychological interventionPharmacistTraining manualPharmacistsCommunicable Diseases030226 pharmacology & pharmacyHospitalsClinical pharmacyAntimicrobial Stewardship03 medical and health sciences0302 clinical medicineAnti-Infective AgentsFamily medicinemedicineHumansInfection controlAntimicrobial stewardship030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsHospital pharmacybusinessAdverse effectOriginal ResearchEuropean Journal of Hospital Pharmacy
researchProduct